MapLight Therapeutics
Executive Director, Clinical Program Management at MapLight Therapeutics leads the Clinical Program Management function, ensuring quality and effectiveness of program management across the clinical development portfolio.
MapLight Therapeutics is a biotechnology company focused on redefining the standard of care for brain disorders through targeted CNS treatments. The company leverages a proprietary discovery platform combining optogenetics, STARmap, and transcriptomics to identify and target individual neural circuits that misfire in brain disorders. Its clinical pipeline includes compounds for schizophrenia, Alzheimer's disease psychosis, and autism spectrum disorder, while its preclinical pipeline addresses Parkinson's disease, hyperactivity, and impulsivity.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MapLight Therapeutics.
118% above the average for this role
Senior Director, Portfolio Management & Operations
Pliant Therapeutics, Inc.
Vice President, Clinical Development
Aurabiosciences
Senior Manager, Regulatory Affairs CMC
Spyre Therapeutics
Director Program Management (m/f/d)
tubulis
Associate Director/Director, Clinical Program Management
Skyhawk Therapeutics
Vice President Pipeline Delivery Systems Process Enablement United States
alnylam